GABELLI FUNDS LLC - CARDLYTICS INC ownership

CARDLYTICS INC's ticker is and the CUSIP is 14161WAB1. A total of 12 filers reported holding CARDLYTICS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
GABELLI FUNDS LLC ownership history of CARDLYTICS INC
ValueSharesWeighting
Q3 2023$2,834,040
+9.3%
4,560,0000.0%0.02%
+15.0%
Q2 2023$2,592,998
+35.7%
4,560,0000.0%0.02%
+42.9%
Q1 2023$1,911,461
-3.6%
4,560,0000.0%0.01%
-6.7%
Q4 2022$1,982,916
-33.6%
4,560,000
-7.3%
0.02%
-40.0%
Q3 2022$2,987,000
-42.9%
4,920,000
-28.9%
0.02%
-37.5%
Q2 2022$5,234,000
-26.6%
6,920,0000.0%0.04%
-14.9%
Q1 2022$7,128,000
+6.6%
6,920,000
+15.0%
0.05%
+11.9%
Q4 2021$6,687,000
+11.4%
6,020,000
+26.2%
0.04%
+5.0%
Q3 2021$6,005,0004,770,0000.04%
Other shareholders
CARDLYTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
683 Capital Management, LLC 16,025,000$9,775,2500.76%
LINDEN ADVISORS LP 58,112,000$36,491,1400.37%
WOLVERINE ASSET MANAGEMENT LLC 33,928,000$21,104,6880.24%
DeepCurrents Investment Group LLC 5,663,000$3,433,4420.15%
CAPSTONE INVESTMENT ADVISORS, LLC 20,160,000$12,511,2960.06%
GABELLI FUNDS LLC 4,560,000$2,834,0400.02%
Verition Fund Management LLC 1,784$1,107,1500.01%
Citadel Advisors 84,195,000$57,252,6000.01%
GAMCO INVESTORS, INC. ET AL 300,000$186,4500.00%
MORGAN STANLEY 130,000$80,0020.00%
View complete list of CARDLYTICS INC shareholders